Price
Historical dividends and forecast
Roche Hldg has so far distributed $10.82 in 2024. The next dividend will be paid on 18.03.2025
CHART BY
Frequently asked questions
What is Roche Hldg's market capitalization?
What is Roche Hldg's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Roche Hldg?
What are the analyst ratings and target price for Roche Hldg's stock?
What is Roche Hldg's revenue over the trailing twelve months?
What is the EBITDA for Roche Hldg?
What is the free cash flow of Roche Hldg?
What is the 5-year beta of Roche Hldg's stock?
How many employees does Roche Hldg have, and what sector and industry does it belong to?
What is the free float of Roche Hldg's shares?
Financials
Market Cap
$242.53B5Y beta
0.72EPS (TTM)
$14.91Free Float
719.12MP/E ratio (TTM)
19.89Revenue (TTM)
$66.25BEBITDA (TTM)
$25.20BFree Cashflow (TTM)
$3.74BPricing
Analyst Ratings
The price target is $306.47 and the stock is covered by 23 analysts.
Buy
9
Hold
9
Sell
5
Information
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
103,605
Biotechnology & Drugs
Health Care
Identifier
ISIN